Condition
Hepatitis clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Hepatitis clinical trials that are recruiting, at sites in 8 countries (most in Italy (2), Taiwan (1), China (1)). By phase: Phase 2 (1), Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 8Countries
Newest Hepatitis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ePro Diary for people with HDV (MACROLIVER) | — | Bergamo, Italy | Recruiting | Mar 2, 2026 |
| Larsucosterol for people with severe alcohol-associated hepatitis | Phase 3 | Birmingham, Alabama and 91 other locations | Recruiting | Feb 23, 2026 |
| Investigating symptoms and blood test characteristics of acute hepatitis in children | — | Bologna and 1 other locations | Recruiting | Jan 7, 2025 |
| Comparing two types of ultrasound for patients with viral hepatitis | — | Lausanne, Canton of Vaud | Recruiting | Aug 26, 2024 |
| Low dead-space syringe and needle distribution for people who inject drugs in low- and middle-income countries | — | Yerevan and 8 other locations | Recruiting | May 1, 2024 |
| Evaluating HepaCure for treating acute-on-chronic liver failure in Chinese patients | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Aug 14, 2023 |
| Evaluating TYNADOTE® for treating acetaminophen overdose | Phase 2 | Taipei, Beitou District | Recruiting | Sep 28, 2022 |
All recruiting trials (7)
-
ePro Diary for people with HDV (MACROLIVER)
This project will try a mobile ePro diary app to help adults with Delta hepatitis (HDV) track symptoms and share health information with their care team.
-
Larsucosterol for people with severe alcohol-associated hepatitis
This trial will test whether larsucosterol helps people with severe alcohol-associated hepatitis survive 90 days without needing a liver transplant.
-
Investigating symptoms and blood test characteristics of acute hepatitis in children
This study is trying to learn more about the symptoms and blood test results of children with acute hepatitis to help doctors recognize and manage the condition better.
-
Comparing two types of ultrasound for patients with viral hepatitis
This study is testing whether a new ultraportable ultrasound is better than the regular ultrasound for helping patients with viral hepatitis get accurate diagnoses and feel more comfortable during the process.
-
Low dead-space syringe and needle distribution for people who inject drugs in low- and middle-income countries
This program will test whether offering low dead-space syringes and needles to people who inject drugs at needle and syringe programs in several low- and middle-income countries increases acceptability and use of safer injecting equipment.
-
Evaluating HepaCure for treating acute-on-chronic liver failure in Chinese patients
This study is testing if a new liver support system called HepaCure, used with another treatment, can help Chinese patients with acute-on-chronic liver failure feel better compared to using the other treatment alone.
-
Evaluating TYNADOTE® for treating acetaminophen overdose
This study is testing if TYNADOTE® can help people who have overdosed on acetaminophen feel better and recover more effectively when given alongside standard treatment.
Related topics
Quick answers
How many Hepatitis clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in Italy (2 trials), Taiwan (1 trial), China (1 trial), United States (1 trial), Armenia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.